Tamiflu's Japanese sales to drop by half

What do Tokyo teenagers falling from buildings have in common with Roche? Possibly Tamiflu. The Japanese government restricted Tamiflu use in teenagers in March, after the falls were reported. Prescriptions dropped, and not just among teenagers. They dropped so far, in fact, that Roche's Japanese partner Chugai now expects to sell only 6 million treatment courses this flu season, compared with 12 million in years past.

In announcing that its Tamiflu supply would be cut in half, Chugai hastened to note that "no causal association between Tamiflu and these events has been determined." And the company pledged to have back-up plans in case a severe flu season leads to increased demand.

- read the press release from Chugai
- check out the Forbes report

Related Articles:
Roche's Tamiflu ads spark criticism. Report
Tamiflu could halve deaths in event of pandemic. Report
EU approves Tamiflu for children. Report

Suggested Articles

Eli Lilly is investing $400 million in its Indianapolis site to expand production of insulin and other diabetes meds, and add 100 jobs.

Mobile has become universal, accessible, and multi-generational. It’s time for life science brands to revolutionize how they’re telling their story.

Former Retrophin CEO was hoping for a SCOTUS hail mary to escape his seven-year fraud sentences Turns out the court was interest in hearing his plea.